|1.||Wang, Hou-Ren: 1 article (01/2008)|
|2.||Yu, Lung-Chih: 1 article (01/2008)|
|3.||Hsieh, Chuang-Yi: 1 article (01/2008)|
|4.||Twu, Yuh-Ching: 1 article (01/2008)|
|5.||Santini, Donatella: 1 article (07/2007)|
|6.||Malagolini, Nadia: 1 article (07/2007)|
|7.||Dall'Olio, Fabio: 1 article (07/2007)|
|8.||Chiricolo, Mariella: 1 article (07/2007)|
|1.||Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/01/2008 - "In this study, a putative CpG island encompassing the promoter and exon 1 regions in the human Sd(a) beta4GalNAcT-II gene was identified, and the investigation of DNA methylation of the Sd(a) gene promoter region demonstrated a clear association between the methylation status of the CpG island promoter and expression of the Sd(a) gene in gastrointestinal cancer cell lines. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
|3.||Stomach Neoplasms (Stomach Cancer)
|4.||Colonic Neoplasms (Colon Cancer)
07/01/2007 - "These data indicate that in colon cancer tissues, the sLex antigen is regulated mainly by the total FucT activity on 3'-sialyllactosamine acceptors and that beta4GalNAcT-II can inhibit sLex expression in an experimental model, although not in colon cancer tissues."
07/01/2007 - "In view of the possible competition between beta4GalNAcT-II and the fucosyltransferases (FucTs) synthesizing the sLex antigen, we investigated whether beta4GalNAcT-II acts as a negative regulator of sLex expression in colon cancer. "
07/01/2007 - "beta4GalNAcT-II cDNA, when expressed in LS174T colon cancer cells, induces the expression of the Sd(a) antigen, a dramatic inhibition of sLex expression on cell membranes, and the replacement of sLex with the Sd(a) antigen on 290 kDa glycoproteins. "
|1.||Complementary DNA (cDNA)